This research demonstrates a solar-driven system converting methane and carbon dioxide into hydrogen and 4-hydroxybenzoate, suggesting new pathways for sustainable energy.
Valorization of decentralized one‐carbon chain (C 1 ) resources into value‐added products has garnered significant attention, owing to its dual benefits in resource recovery and carbon mitigation. To address the challenge of co‐converting methane (CH 4 ) and carbon dioxide (CO 2 ), we developed a solar‐driven biohybrid system that synergistically integrates biosynthesis and photocatalysis. The core of this system relies on a genetically engineered methanotrophic cell factory and newly designed biocompatible photocatalytic metal complexes. The methanotrophic bacteria utilize CH 4 as the primary feedstock to biosynthesize 4‐hydroxybenzoate (4HBA) while realizing CO 2 sequestration. The photocatalytic metal complexes, meanwhile, capture formate (a metabolic byproduct of cells) to generate hydrogen (H 2 ) and photoelectrons—with the latter directly supplying reducing power to support cellular activities in genetically tailored cells. Under optimal conditions, this solar‐driven system achieved a 4HBA titer of 472.36 µg/L, a H 2 yield of 0.59 mmol H 2 /mol CH 4 , and over 50% reduction in carbon emissions. The study not only establishes a feasible biomanufacturing strategy for the upcycling of C 1 gaseous feedstocks but also highlights the potential of integrating biological and photochemical technologies to advance sustainable energy and environmental solutions.
No takes yet. Share an insight, caveat, or question.
Jiao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: